ObvioHealth’s Post

🚀 Exciting News from ObvioHealth! 🚀 We're thrilled to announce a major milestone in our journey to revolutionize clinical research. As we continue to mature, ObvioHealth is transitioning from a Virtual Research Organization (VRO) to a leading enterprise software provider, focused on delivering advanced, scalable, and efficient digital solutions through our ObvioGo® platform. We have partnered with leading CROs to provide related clinical services and complement ObvioHealth's offerings. To reflect this strategic shift, we've revamped our website to spotlight our software-focused offerings. Our new site highlights the ObvioGo® enterprise solution, designed to deliver unmatched flexibility, scalability, and efficiency in clinical trials. Whether managing large-scale or smaller studies, ObvioGo® is here to support success at every step. A key component of our enterprise solution is the comprehensive training provided by our enablement team. We’re committed to guiding our clients through every phase of study design and delivery, ensuring they’re fully equipped to leverage the power of ObvioGo®. We're excited to embark on this new chapter and continue pushing the boundaries of what's possible in clinical research. Stay tuned for more updates and visit our new website to learn how ObvioGo® can revolutionize your clinical trials! https://lnkd.in/gMrDd-W5 #ClinicalResearch #DigitalHealth #Innovation #ObvioHealth #ObvioGo #SaaS #SoftwareSolutions

📊 Streamline Your Clinical Trials with ObvioHealth’s Study Manager   Managing decentralized and hybrid trials is challenging. ObvioHealth’s Study Manager simplifies the process by centralizing consent workflows, integrating eCRF and eClinRo for televisit assessments, and providing real-time compliance monitoring.   Gain instant visibility into data quality, manage patient safety with ease, and handle protocol deviations — all from one secure platform. Enhance your trial management today.   Ready to take the next step? Schedule a demo with our team!   #ClinicalTrials #DecentralizedTrials #HybridTrials #ClinicalResearch #ObvioHealth #ObvioGo #StudyManagement

Streamline Your Clinical Trial Design with ObvioHealth's Study Designer!   At ObvioHealth, we're simplifying the way clinical trials are designed. The Study Designer gives your team the tools to create, test, and launch studies more efficiently, all without the need for coding or engineering support.   With a user-friendly drag-and-drop interface and the ability to handle complex workflows, you can design studies that are both robust and adaptable.   Ready to see how it works? Book a demo today to explore the possibilities. #ClinicalTrials #StudyDesign #HealthcareInnovation #ObvioHealth

Transform Your Clinical Research Experience with ObvioGo 2.0, a cutting-edge platform designed to simplify and optimize your clinical trials, providing you with the tools you need for success. Explore key features like our Study Designer Module, Study Manager Module, and the ObvioGo App. See firsthand how ObvioGo 2.0 can revolutionize your research process. Discover more and schedule a demo today! https://lnkd.in/dFmvkjtE #ClinicalResearch #DigitalHealth #Innovation #ObvioGo #ResearchSimplified

Didn’t have time to watch our latest #webinar? Access all the key insights you missed with this easy-to-read, downloadable summary. Get your copy: https://lnkd.in/gi6WQDZv

Exciting News! ObvioHealth is thrilled to announce a strategic investment by Guardant Health to accelerate the deployment of oncology clinical trials globally. This partnership is a significant step forward in our mission to revolutionize cancer research and bring innovative treatments to patients faster.   Key Highlights: 🌍 Global Reach: With Guardant Health's investment, we aim to expand our oncology trials worldwide, reaching more patients and researchers. 🚀 Enhanced Capabilities: Combining our digital clinical trial solutions with Guardant Health's cutting-edge technology will enhance trial efficiency and data accuracy. 💗 Patient-Centric Approach: Our focus remains on improving patient outcomes and providing seamless trial experiences through our advanced digital platform. "ObvioHealth sees tremendous opportunity in this partnership," said Ivan Jarry, Chief Executive Officer at ObvioHealth. "Guardant's network of researchers enables us to further penetrate the oncology therapeutic area and helps us to expand this important research beyond the 35 countries where we are already conducting trials." Join us on this exciting journey as we work together to transform the landscape of oncology clinical trials. Read the full press release to learn more about this strategic investment: ObvioHealth announces strategic investment by Guardant Health (prnewswire.com) #Oncology #ClinicalTrials #DigitalHealth #CancerResearch #Innovation #ObvioHealth

Patients can become demotivated when #ePRO tasks are too long or complicated. In fact, anything that creates friction in the reporting journey can have a negative impact on engagement. To improve outcomes quality, a more patient-centric approach is required. Learn more: https://lnkd.in/djwM5EtY

Don’t settle for digitized versions of poor traditional assessments. ObvioHealth’s #ePRO optimizes #data collection to deliver the #accuracy you need. Learn more: https://lnkd.in/d6CRD_tr

When #clinicaltrials are designed to truly #measurewhatmatters, the result is stronger #therapeutic evidence. Learn more about the 5 key #benefits that measuring what matters can bring to your #clinicaltrial: https://lnkd.in/gR6ypXnS

For Steve Schaefer, CEO of Mi-Helper, Inc., the idea of conducting a #digital #clinicaltrial was daunting—but only at first. Listen in as he describes how working with ObvioHealth helped him to overcome his hesitations and address his past clinical research pain points. Watch the full testimonial: https://lnkd.in/gzw_Nsv6